IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.960
EU - Europa 6.111
AS - Asia 3.759
SA - Sud America 22
OC - Oceania 21
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 21.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.898
CN - Cina 1.987
UA - Ucraina 1.764
PL - Polonia 923
IT - Italia 794
SG - Singapore 732
DE - Germania 703
FI - Finlandia 459
FR - Francia 411
HK - Hong Kong 379
GB - Regno Unito 328
IE - Irlanda 286
TR - Turchia 279
IN - India 249
RU - Federazione Russa 229
CA - Canada 59
SE - Svezia 59
BE - Belgio 50
CZ - Repubblica Ceca 46
VN - Vietnam 44
IR - Iran 36
AU - Australia 19
CH - Svizzera 15
EU - Europa 15
ID - Indonesia 14
MU - Mauritius 14
BR - Brasile 10
KR - Corea 8
NL - Olanda 8
CL - Cile 7
ES - Italia 6
IL - Israele 5
JP - Giappone 5
RO - Romania 5
BG - Bulgaria 4
GR - Grecia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
HU - Ungheria 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BZ - Belize 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TH - Thailandia 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 21.908
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.486
Jacksonville 1.286
Warsaw 923
Houston 905
Ann Arbor 790
Ashburn 777
Cambridge 681
Singapore 629
Chandler 579
Seattle 576
Wilmington 569
Princeton 527
Nanjing 466
Hong Kong 376
Brescia 294
Dublin 284
Dearborn 279
Beijing 278
Istanbul 235
New York 220
Helsinki 219
Nanchang 181
Shenyang 146
Hebei 131
Des Moines 118
Moscow 110
Jinan 96
Tianjin 96
Milan 85
Changsha 82
San Diego 77
Shanghai 76
Pune 71
Jiaxing 66
Lancaster 64
Toronto 49
San Mateo 48
Kunming 47
Brussels 44
Hangzhou 43
Dong Ket 42
Verona 42
Ningbo 39
Brno 38
Munich 38
Kocaeli 36
Augusta 33
Ardabil 32
Leawood 32
London 32
San Francisco 32
San Donà Di Piave 31
Haikou 28
Zhengzhou 28
Los Angeles 27
Monmouth Junction 27
Taizhou 27
Boardman 24
Romola 23
Lanzhou 20
Guangzhou 19
Norwalk 17
Orange 15
Rome 15
Basel 14
Changchun 14
Fuzhou 14
Jakarta 14
Taiyuan 14
Hefei 13
Kilburn 12
Auburn Hills 11
Canberra 9
Acton 8
Mumbai 7
New Bedfont 7
Olomouc 7
Redwood City 7
São Paulo 7
Teramo 7
Brooklyn 6
Lappeenranta 6
Melbourne 6
Ottawa 6
Hounslow 5
Phoenix 5
Santa Clara 5
Bologna 4
Hanover 4
Madrid 4
Oxford 4
Paris 4
Sofia 4
Torino 4
Xian 4
Bishkek 3
Bolzano 3
Cattolica 3
Chiswick 3
Totale 16.523
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 257
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 253
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 239
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 229
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 217
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 212
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 191
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 189
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 163
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 159
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 158
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 151
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 143
Palbociclib inhibits proliferation of human adrenocortical tumor cells 138
The D3 dopamine receptor: From structural interactions to function. 136
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 131
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 129
Age-related changes of enkephalin in rat spinal cord 128
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 128
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 127
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 127
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 125
A new pharmacological approach to the facilitation of acetylcholine transmission. 124
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 124
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 123
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 120
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 119
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 118
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 117
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 116
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 115
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 115
Pharmacological basis for dopamine D-2 receptor diversity 113
Synapsin III alterations in Parkinson's disease 113
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 112
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 112
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 112
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 112
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 111
Ormoni Anteroipofisari 110
Dopamine receptors are present in rat and human esophagus 110
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 110
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 109
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 109
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 108
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 108
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 108
Vasoactive Intestinal Polypeptide (VIP) selectively stimulates prolactin release in healthy women 108
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 108
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 108
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 108
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 107
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 107
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 107
Sex-related variations in serum nerve growth factor concentration in humans. 106
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 106
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 106
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 106
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 106
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 105
Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens 105
Nerve growth factor, D2 receptor isoforms, and pituitary tumors 105
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 103
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 103
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 103
A superfusion method for the study of calcium fluxes from pituitary cells. 103
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 102
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 102
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 101
Different neurotransmitter systems are involved in the development of esophageal achalasia 101
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 101
The NMDA/D1 receptor complex as a new target in drug development 101
Caveolins in rhabdomyosarcoma 101
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 101
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 100
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 99
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 99
Dopamine D2 receptors modulate aldosterone secretion 99
Nerve growth factor signaling in prostate health and disease. 99
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter 97
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 97
Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus 97
Nerve growth factor in pituitary development and pituitary tumors 97
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 97
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 97
Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH23390 binding 96
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 96
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 96
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 96
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 96
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 96
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 96
Identification and characterization of postsynaptic D1 and D2 dopamine receptors in the cardiovascular system 94
Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex 94
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 94
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 93
Inhibition of aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors. 93
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 93
NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord 92
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 92
Totale 11.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.804 0 0 0 0 0 712 603 681 377 853 223 355
2020/20213.673 79 401 84 409 123 411 193 465 565 287 536 120
2021/20222.156 195 455 54 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.763 110 32 142 132 93 372 60 53 387 30 44 308
2024/20251.477 23 46 58 545 471 334 0 0 0 0 0 0
Totale 22.726